IRIS

Atazanavir and lopinavir represent the main HIV protease inhibitors recommended in pregnancy, but comparative data in pregnant women are limited.

Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

SPINILLO, ARSENIO;
2014-01-01

Abstract

Atazanavir and lopinavir represent the main HIV protease inhibitors recommended in pregnancy, but comparative data in pregnant women are limited.
2014
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
sì
WOS:000334688400029
2-s2.0-84898467141
Esperti anonimi
Inglese
Internazionale
STAMPA
69
5
1377-84
24370933
HIV RNA; bilirubin; cholesterol; pre-term delivery; triglycerides; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lipids; Liver Function Tests; Lopinavir; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridines; RNA, Viral; Viral Load
13
info:eu-repo/semantics/article
262
Floridia, Marco; Ravizza, Marina; Masuelli, Giulia; Giacomet, Vania; Martinelli, Pasquale; Degli Antoni, Anna; Spinillo, Arsenio; Fiscon, Marta; Franc...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1101042
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact